| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/02/2002 | US6413517 Identification of broadly reactive DR restricted epitopes |
| 07/02/2002 | US6413516 Suppression lymphocytes |
| 07/02/2002 | US6413511 Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide |
| 07/02/2002 | US6413507 Modified polyether |
| 07/02/2002 | US6413499 Absorption; controlling concentration to nasal cavity |
| 07/02/2002 | US6413497 Inhalation |
| 07/02/2002 | US6413494 Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 07/02/2002 | US6412492 Mixed chimerism and tolerance |
| 07/02/2002 | US6412336 Single riser/single capillary blood viscometer using mass detection or column height detection |
| 07/02/2002 | CA2333528C A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer |
| 07/02/2002 | CA2255955C Cosmetic compositions |
| 07/02/2002 | CA2253837C Therapeutic uses of bpi protein products for human meningococcemia |
| 07/02/2002 | CA2253080C 5-substituted picolinic acid compounds and their production process |
| 07/02/2002 | CA2247748C Resorcinol derivatives |
| 07/02/2002 | CA2201163C Utilization of an extract of at least one iridacea in the treatment of wrinkles |
| 07/02/2002 | CA2194984C 4-indole derivatives as serotonin agonists and antagonists |
| 07/02/2002 | CA2184908C Human osteoclast-derived cathepsin |
| 07/02/2002 | CA2152487C Method for treating a medical patient for cardiac trauma |
| 07/02/2002 | CA2137755C Palliation of sickle cell disorders by phenylurea, benzylurea, or phenylethylurea or by a homolog ring-substituted with one methoxyl, methyl, or hydroxyl radical |
| 07/02/2002 | CA2124315C Nitroaniline derivatives and their use as antitumor agents |
| 07/02/2002 | CA2109601C Amide derivatives of antibiotic a 40926 |
| 07/02/2002 | CA2065846C Quinolone carboxylic acid derivatives |
| 07/02/2002 | CA2064478C Ophthalmic composition |
| 07/02/2002 | CA2061703C Formulations containing hyaluronic acid |
| 07/02/2002 | CA2047283C Pyrazolopyridine compound and processes for preparation thereof |
| 07/02/2002 | CA2030875C Methods and probes for detecting nucleoside transporter and method for producing the probes |
| 07/02/2002 | CA2022119C Substituted aromatic sulfonamides as antiglaucoma agents |
| 07/02/2002 | CA2018149C Aminoketone compounds |
| 07/02/2002 | CA2006372C Process for preparing isothiocyanato functionalized metal complexes |
| 07/02/2002 | CA1341373C Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates |
| 06/27/2002 | WO2002050288A1 Neocentromere-based mini-chromosomes or artificial chromosomes |
| 06/27/2002 | WO2002050284A2 Oxidoreductases |
| 06/27/2002 | WO2002050278A2 Novel human secreted proteins and polynucleotides encoding the same |
| 06/27/2002 | WO2002050257A2 Method for the production of polyfructans |
| 06/27/2002 | WO2002050221A1 A process for preparing vegetable oil fractions rich in non-tocolic, high-melting, unsaponifiable matter |
| 06/27/2002 | WO2002050125A2 Glycosaminoglycans derived from k5 polysaccharide having high antithrombin activity and process for their preparation |
| 06/27/2002 | WO2002050096A1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | WO2002050093A2 Methods utilizing aryl thioimines in synthesis of erythromycin derivatives |
| 06/27/2002 | WO2002050092A1 Macrolide antibiotics |
| 06/27/2002 | WO2002050091A1 Macrolide antibiotics |
| 06/27/2002 | WO2002050090A1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 06/27/2002 | WO2002050089A1 Method for purification of lactose |
| 06/27/2002 | WO2002050084A2 Streptogramin derivatives preparation thereof and compositions containing same |
| 06/27/2002 | WO2002050083A1 Streptogramin derivatives, preparation thereof and compositions containing same |
| 06/27/2002 | WO2002050082A2 Inhibitors of papilloma virus |
| 06/27/2002 | WO2002050079A1 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors |
| 06/27/2002 | WO2002050078A1 Novel substituted imidazotriazinones as pde ii-inhibitors |
| 06/27/2002 | WO2002050073A1 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 06/27/2002 | WO2002050071A1 Thiazolyl inhibitors of tec family tyrosine kinases |
| 06/27/2002 | WO2002050070A2 Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists |
| 06/27/2002 | WO2002050068A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| 06/27/2002 | WO2002050067A2 Pharmaceutical heterocyclic compounds |
| 06/27/2002 | WO2002050066A2 Pyrazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002050065A2 Pyrazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002050064A1 Substituted pyrrolidines as ccr-3 receptor antagonists |
| 06/27/2002 | WO2002050063A1 New process |
| 06/27/2002 | WO2002050062A2 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors |
| 06/27/2002 | WO2002050061A1 Piperazine derivatives for treatment of bacterial infections |
| 06/27/2002 | WO2002050060A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| 06/27/2002 | WO2002050058A1 Crystal forms of 6-[(4-chloro-phenyl) -hydroxy-(-3-methyl- 3h-imidaol-4-yl) -methyl] -4-(3-ethynyl-phenyl) -1-methyl-1h- quinolin-2-one, 2,3- dihydroxybutanedioate salts and method of production |
| 06/27/2002 | WO2002050057A1 Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders |
| 06/27/2002 | WO2002050056A1 Benzylamine derivatives and their use as thrombin inhibitors |
| 06/27/2002 | WO2002050051A1 Chemical compounds |
| 06/27/2002 | WO2002050050A1 2-(2-(4-((2r)-2-methyl-3-(10h-phenothiazin-10-yl)propyl)-1-piperazinyl)-ethoxy)ethanol, process for the preparation thereof, pharmaceutical compositions containing said compound and therapeutic uses thereof |
| 06/27/2002 | WO2002050049A1 1,1-dioxo-2h-1, 2-benzothiazine-3-carboxamide derivatives, method for preparing same and pharmaceutical compositions comprising same |
| 06/27/2002 | WO2002050047A1 Substitued oxazoles and thiazoles as hppar alpha agonists |
| 06/27/2002 | WO2002050046A1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 06/27/2002 | WO2002050045A1 Antiviral agents |
| 06/27/2002 | WO2002050044A1 Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient |
| 06/27/2002 | WO2002050043A1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof |
| 06/27/2002 | WO2002050041A1 Dihydroindole and tetrahydroquinoline derivatives |
| 06/27/2002 | WO2002050040A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents |
| 06/27/2002 | WO2002050039A1 Urea and urethane derivatives as integrin inhibitors |
| 06/27/2002 | WO2002050036A1 Crystalline forms of cerivastatin sodium |
| 06/27/2002 | WO2002050034A2 Tetracyclic carbazole derivates and their use as spla2 inhibitors |
| 06/27/2002 | WO2002050033A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands |
| 06/27/2002 | WO2002050032A1 Naphthalene derivatives which bind to the ep4 receptor |
| 06/27/2002 | WO2002050031A1 Indole derivatives |
| 06/27/2002 | WO2002050030A2 Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases |
| 06/27/2002 | WO2002050029A2 Tetracyclic derivatives as spla2 inhibitors |
| 06/27/2002 | WO2002050028A2 Substituted benzoindoles as spla2 inhibitors |
| 06/27/2002 | WO2002050027A1 Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
| 06/27/2002 | WO2002050024A2 Thiazolidinediones |
| 06/27/2002 | WO2002050021A1 Nitric oxide synthase inhibitor phosphate salt |
| 06/27/2002 | WO2002050019A2 Diamines as modulators of chemokine receptor activity |
| 06/27/2002 | WO2002050018A1 Dihydroceramide desaturase inhibitors. |
| 06/27/2002 | WO2002050013A1 Carboxylic acid compound having cyclopropane ring |
| 06/27/2002 | WO2002050008A2 Non-halogenated phenoxy and/or benzyloxy phenols and antimicrobial compositions containing them |
| 06/27/2002 | WO2002050001A2 Non-halogenated naphthol compounds and antimicrobial compositions containing the same |
| 06/27/2002 | WO2002049993A2 High affinity small molecule c5a receptor modulators |
| 06/27/2002 | WO2002049675A1 Compositions of estrogen-cyclodextrin complexes |
| 06/27/2002 | WO2002049674A1 Cyclodextrin-drospirenone inclusion complexes |
| 06/27/2002 | WO2002049670A1 Preventives or remedies for endometriosis |
| 06/27/2002 | WO2002049656A1 External skin preparations and process for producing the same |
| 06/27/2002 | WO2002049654A1 Shark meat extract |
| 06/27/2002 | WO2002049652A1 Method of treatment |
| 06/27/2002 | WO2002049651A1 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidines and antithrombotic agents, calcium-antagonists, prostaglandins or prostaglandin derivatives |
| 06/27/2002 | WO2002049650A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives |
| 06/27/2002 | WO2002049649A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
| 06/27/2002 | WO2002049648A1 Heteroaryl urea neuropeptide y y5 receptor antagonists |